Connect with us

Hi, what are you looking for?

Friday, Apr 18, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "biotech"

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease

Medical and Pharmaceutical

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease

This approval is a hard-won victory for Soleno after a lengthy clinical trial phase

Joseph MortonMarch 27, 2025

Intranasal drug delivery system developer Polyrizon prepares to administer psychedelics

Intranasal drug delivery system developer Polyrizon prepares to administer psychedelics

Psychedelics

Intranasal delivery tech developer ‘Polyrizon’ plans to administer psychedelics

The Israeli company has an unnamed new partner involved with unspecified psychedelic drugs

Rowan DunneMarch 18, 2025

MindBio Therapeutics can use AI speech analysis to see if you've taken its LSD drug

MindBio Therapeutics can use AI speech analysis to see if you've taken its LSD drug

Psychedelics

MindBio Therapeutics uses AI speech analysis to see if you’ve taken its LSD drug

The biopharma operator's lead drug candidate, MB22001, was created for microdosing

Rowan DunneJanuary 24, 2025

Phio Pharmaceuticals skyrockets on skin cancer drug trial results

Phio Pharmaceuticals skyrockets on skin cancer drug trial results

Medical and Pharmaceutical

Phio Pharmaceuticals skyrockets on skin cancer drug trial success

Shareholders are having a pretty stellar Monday with the immense gains

Rowan DunneJanuary 13, 2025

IGM Biosciences slides by 66% on discontinued drug development and lay offs

IGM Biosciences slides by 66% on discontinued drug development and lay offs

Science and Research

IGM Biosciences slides by 66% on discontinued drug development and lay offs

The biotech company has put the halt on 2 therapeutics used to treat arthritis, lupus and myasthenia gravis

Rowan DunneJanuary 10, 2025

SILO Pharma flies high on patent for intranasal PTSD treatment drug

SILO Pharma flies high on patent for intranasal PTSD treatment drug

Medical and Pharmaceutical

SILO Pharma flies high on impending patent for intranasal PTSD drug

The stock rose by 146% in early morning trading on the Nasdaq

Rowan DunneJanuary 8, 2025

Hoth Therapeutics up over 200% on dermatology breakthrough for cancer patients

Hoth Therapeutics up over 200% on dermatology breakthrough for cancer patients

Medical and Pharmaceutical

Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients

The biopharma operator's 'HT-001" drug was highly successful in alleviating skin issues caused by a cancer treatment

Rowan DunneJanuary 7, 2025

RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement

RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement

Medical and Pharmaceutical

RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement

The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world

Rowan DunneDecember 23, 2024

Neurogene patient dies in drug trial, stock surges after FDA says 'use lower dose'

Neurogene patient dies in drug trial, stock surges after FDA says 'use lower dose'

Medical and Pharmaceutical

Neurogene patient dies in drug trial, stock surges after FDA says ‘use lower dose’

This unfortunate incident occurred during a study on the company's Rett syndrome therapeutic NGN-401

Rowan DunneNovember 22, 2024

Breath Diagnostics onboard new president and closes critical financing

Breath Diagnostics onboard new president and closes critical financing

Health & Wellness

Breath Diagnostics onboards new president and closes critical financing

Aaron Roebuck brings three decades of experience in respiratory and cardiopulmonary medicine, and commercialization of medical devices

Joseph MortonOctober 31, 2024

More Posts

Page 1 of 212